Statistics for Gilead Sciences (id:7062 GILD)
Valuation metrics
Market cap
115.37B
Enterprise value
131.83B
Trailing P/E (ttm)
1.03K
Forward P/E
12.46
PEG ratio
12.46
Price/Sales (ttm)
4.08
Price/Book (mrq)
6.24
Enterprise Value/Revenue
4.66
Enterprise Value/EBITDA
9.45
Overview
Shares outstanding
1.25B
Float
1.24B
Shares short
23.41M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
8.62M
Average volume (90 days)
Price summary
52-Week low
62.07
52-Week high
98.90
52-Week change
13.63%
Beta
3.00
50-Day moving average
90.49
200-Day moving average
76.98
Dividends and splits
Forward annual dividend rate
3.08
Forward annual dividend yield
5.00
Trailing annual dividend rate
3.06%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
4.02
Payout ratio
34.00
Dividend date
December 30, 2024
Ex-dividend date
December 13, 2024
Last split factor
2:1
Last split date
January 28, 2013
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
3.00%
Operating margin
41.96%
Operational effectiveness
Return on assets
11.96%
Return on equity
3.00%
Income statement
Revenue (ttm)
22.70
Revenue per share (ttm)
22.70
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
20.62B
EBITDA
10.48B
Net income to common (ttm)
126.00M
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
-42.50%
Balance sheet
Total cash (mrq)
6.70B
Total cash per share (mrq)
5.37
Total debt (mrq)
23.25B
Total Debt/Equity (mrq)
126.42
Current ratio (mrq)
126.00%
Book value per share (mrq)
14.83
Cash flow
Cash flow statement
10.02B
Levered free cash flow (LFCF)
9.08B